Exercise Programs for Hidradenitis Suppurativa
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to design and test exercise programs for people with hidradenitis suppurativa (HS), a skin condition that causes painful lumps. Researchers seek to understand the challenges HS patients face with physical activity and explore how exercise can help. Participants will follow either a personalized home exercise program for up to 12 weeks or a shorter exercise program. The trial seeks individuals diagnosed with moderate-to-severe HS by a dermatologist. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance exercise recommendations for HS patients.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that these exercise programs are safe for HS patients?
Research shows that home-based exercise programs are generally safe. These programs have been tested in other conditions, such as a type of muscular dystrophy, and have been well-received. For individuals with hidradenitis suppurativa (HS), the main concerns with exercise are sweating and pain. While sweating is a normal part of exercising, it can be uncomfortable for those with HS. However, these exercise programs have not revealed any serious safety issues. Participants in similar studies successfully managed these concerns.12345
Why are researchers excited about this trial?
Researchers are excited about the exercise programs being studied for hidradenitis suppurativa because they're exploring a non-drug approach to manage this challenging skin condition. Most current treatments focus on medications like antibiotics, biologics, or surgery to reduce inflammation and manage symptoms. However, these exercise programs aim to improve patients' quality of life through physical activity, potentially reducing flare-ups and pain. The Home Exercise Program offers a personalized routine that participants can follow at home for up to 12 weeks, providing flexibility and convenience. The Short Exercise Program serves as a comparator, allowing researchers to evaluate the effectiveness of different exercise durations and intensities.
What evidence suggests that these exercise programs could be effective for Hidradenitis Suppurativa?
This trial will compare two exercise programs for managing symptoms of hidradenitis suppurativa (HS), a long-term skin condition. Participants in one arm will follow a Home Exercise Program, a personalized plan designed to be safe and effective for people with HS. Another arm will involve a Short Exercise Program. Research has shown that exercise can improve skin health by reducing inflammation and enhancing overall well-being. However, some people find exercise difficult due to sweating and pain, so personalized exercise plans that address these challenges can be beneficial. Regular physical activity has also been proven to help with chronic pain, which is common for those with HS.12367
Who Is on the Research Team?
Hadar Lev-Tov, MD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for adults aged 18-80 with Hidradenitis Suppurativa (HS) confirmed by a dermatologist. Participants must be able to consent and, for part of the study, have moderate-to-severe HS as per IHS-4 criteria. Pregnant women, minors, prisoners, or those unable to follow the study procedures are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow an at-home personalized exercise program for up to 12 weeks
Follow-up
Participants are monitored for changes in functional strength, physical activity, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Home Exercise Program
- Short Exercise Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor